Wang, L. et al. Prevalence and treatment of diabetes in China, 2013–2018[J]. JAMA 326(24), 2498–2506 (2021).
Sun, H. et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res. Clin. Pract. 183, 109119 (2022).
Ccorahua-Rios, M. S. et al. Type 2 diabetes mellitus prevalence between 2005 and 2018 in population under 30 using data from the Ministry of Health of Peru[J]. Medwave 19(10), e7723 (2019).
Tuttle, K. R. et al. Diabetic kidney disease: A report from an ADA Consensus Conference[J]. Diabetes Care 37(10), 2864–2883 (2014).
Yang, C. et al. CKD in China: Evolving spectrum and public health implications[J]. Am. J. Kidney Dis. 76(2), 258–264 (2020).
Wang, M. et al. Incidence and time trends of type 2 diabetes mellitus among adults in Zhejiang Province, China, 2007–2017[J]. J. Diabetes Res. 2020, 2597953 (2020).
Luk, A. et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study[J]. PLoS Med. 17(2), e1003052 (2020).
Zhang, L. et al. Trends in chronic kidney disease in China[J]. N. Engl. J. Med. 375(9), 905–906 (2016).
Lytvyn, Y. et al. The new biology of diabetic kidney disease-mechanisms and therapeutic implications[J]. Endocr. Rev. 41(2), 202–231 (2020).
Matoba, K., Takeda, Y., Nagai, Y., et al. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease.
Int. J. Mol. Sci. 20(14), 3393 (2019).
Winter, L. et al. Use of readily accessible inflammatory markers to predict diabetic kidney disease[J]. Front. Endocrinol. (Lausanne) 9, 225 (2018).
Song, M. et al. Neutrophil-to-lymphocyte ratio and mortality in the United States general population[J]. Sci. Rep. 11(1), 464 (2021).
Vorobjeva, N. V. & Chernyak, B. V. NETosis: Molecular mechanisms, role in physiology and pathology[J]. Biochemistry (Mosc) 85(10), 1178–1190 (2020).
Azab, B. et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction[J]. Am. J. Cardiol. 106(4), 470–476 (2010).
Afari, M. E. & Bhat, T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: An update[J]. Expert Rev. Cardiovasc. Ther. 14(5), 573–577 (2016).
Buonacera, A., Stancanelli, B., Colaci, M. et al. Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the immune system and diseases. Int. J. Mol. Sci. 23(7), 3636 (2022).
Tang, Y. et al. C-reactive protein and ageing[J]. Clin. Exp. Pharmacol. Physiol. 44(Suppl 1), 9–14 (2017).
Aryan, Z. et al. Baseline high-sensitivity c-reactive protein predicts macrovascular and microvascular complications of type 2 diabetes: A population-based study[J]. Ann. Nutr. Metab. 72(4), 287–295 (2018).
Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection[J]. Front. Immunol. 9, 754 (2018).
Chow, F. Y. et al. Macrophages in streptozotocin-induced diabetic nephropathy: Potential role in renal fibrosis[J]. Nephrol. Dial Transpl. 19(12), 2987–2996 (2004).
Wang, Q. et al. Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm[J]. PLoS One 9(3), e92053 (2014).
Yan, Q. et al. Expression and significance of RANTES and MCP-1 in renal tissue with chronic renal allograft dysfunction[J]. Transpl. Proc. 48(6), 2034–2039 (2016).
Hao, W., Rovin, B. H. & Friedman, A. Mathematical model of renal interstitial fibrosis[J]. Proc. Natl. Acad. Sci. USA 111(39), 14193–14198 (2014).
Article
MathSciNet
CAS
PubMed
PubMed Central
ADS
Google Scholar
Levey, A. S. et al. A new equation to estimate glomerular filtration rate[J]. Ann. Intern. Med. 150(9), 604–612 (2009).
Jaaban, M. et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes[J]. Heliyon 7(7), e7564 (2021).
Huang, W. et al. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy[J]. Clin. Endocrinol. (Oxf.) 82(2), 229–233 (2015).
Wan, H. et al. Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: A cross-sectional study[J]. J. Diabetes Res. 2020, 6219545 (2020).
Azab, B. et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study)[J]. Ren. Fail 34(5), 571–576 (2012).
Zhang, J. et al. Effects of neutrophil-lymphocyte ratio on renal function and histologic lesions in patients with diabetic nephropathy[J]. Nephrology (Carlton) 24(11), 1115–1121 (2019).
Tang, M. et al. Association between high-sensitivity c-reactive protein and diabetic kidney disease in patients with type 2 diabetes mellitus[J]. Front. Endocrinol. (Lausanne) 13, 885516 (2022).
Liu, Q. et al. The association between high-sensitivity C-reactive protein concentration and diabetic nephropathy: A meta-analysis[J]. Eur. Rev. Med. Pharmacol. Sci. 19(23), 4558–4568 (2015).
Liu, L. et al. Reduction in serum high-sensitivity C-reactive protein favors kidney outcomes in patients with impaired fasting glucose or diabetes[J]. J. Diabetes Res. 2020, 2720905 (2020).
Guo, S. et al. The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes[J]. BMC Endocr. Disord. 20(1), 103 (2020).
Satirapoj, B. et al. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease[J]. BMC Nephrol. 19(1), 246 (2018).
Shoukry, A., Bdeer, S. & El-Sokkary, R. H. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus[J]. Mol. Cell Biochem. 408(1–2), 25–35 (2015).
Shaker, O. G. & Sadik, N. A. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy[J]. Hum. Exp. Toxicol. 32(10), 1089–1096 (2013).
Scurt, F. G. et al. Monocyte chemoattractant protein-1 predicts the development of diabetic nephropathy[J]. Diabetes Metab. Res. Rev. 38(2), e3497 (2022).
Alicic, R. Z., Rooney, M. T. & Tuttle, K. R. Diabetic kidney disease: Challenges, progress, and possibilities[J]. Clin. J. Am. Soc. Nephrol. 12(12), 2032–2045 (2017).
McGill, J. B. Improving microvascular outcomes in patients with diabetes through management of hypertension[J]. Postgrad. Med. 121(2), 89–101 (2009).
Corriere, T. et al. Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults[J]. Nutr. Metab. Cardiovasc. Dis. 28(1), 23–27 (2018).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41598-024-53567-2